quizartinib
daiichi sankyo
['quizartinib', 'aml,(-streamline),(-seamless),(-kamloops),(-latamleaders)', 'aml,(-streamline),(-seamless),(-kamloops),(-dreamlike)']
 s quizartinib doubles overall survival in patients with newly diagnosed flt3-itd-positive aml #biotech #pharma #eha2022
Biopharma’s trusted news source. Lynn Yoffee, Jennifer Boggs, Anette Breindl, Michael Fitzhugh, Lee Landenberger, Randy Osborne, Mari Serebrov, Richard Staines